{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:52:39Z","timestamp":1790146359299,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11596-020-2163-7","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T02:02:45Z","timestamp":1584064965000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors"],"prefix":"10.1007","volume":"40","author":[{"given":"Yong-ning","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-peng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"issue":"5","key":"2163_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015,136(5):E359\u2013386","journal-title":"Int J Cancer"},{"issue":"7","key":"2163_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/IGC.0000000000000181","volume":"24","author":"J Kaijser","year":"2014","unstructured":"Kaijser J, Van Belle V, Van Gorp T, et al. Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosis. Int J Gynecol Cancer, 2014,24(7):1173\u20131180","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"2163_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","volume":"15","author":"MJ Duffy","year":"2005","unstructured":"Duffy MJ, Bonfrer JM, Kulpa J, et al. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer, 2005,15(5):679\u2013691","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2163_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ygyno.2005.06.040","volume":"99","author":"DG Rosen","year":"2005","unstructured":"Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol, 2005,99(2):266\u2013277","journal-title":"Gynecol Oncol"},{"issue":"25","key":"2163_CR5","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1200\/JCO.2005.08.151","volume":"23","author":"S Paramasivam","year":"2005","unstructured":"Paramasivam S, Tripcony L, Crandon A, et al. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study. J Clin Oncol, 2005,23(25):5938\u20135942","journal-title":"J Clin Oncol"},{"issue":"2","key":"2163_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","volume":"108","author":"RG Moore","year":"2008","unstructured":"Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol, 2008,108(2):402\u2013408","journal-title":"Gynecol Oncol"},{"issue":"7","key":"2163_CR7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/IGC.0b013e318263efa2","volume":"22","author":"L Wu","year":"2012","unstructured":"Wu L, Dai ZY, Qian YH, et al. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis. Int J Gynecol Cancer, 2012,22(7):1106\u20131112","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"2163_CR8","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005,65(6):2162\u20132169","journal-title":"Cancer Res"},{"issue":"1","key":"2163_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"RG Moore","year":"2009","unstructured":"Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2009,112(1):40\u201346","journal-title":"Gynecol Oncol"},{"key":"2163_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2407-12-258","volume":"12","author":"F Li","year":"2012","unstructured":"Li F, Tie R, Chang K, et al. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. BMC Cancer, 2012,12:258","journal-title":"BMC Cancer"},{"key":"2163_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2147\/IJWH.S47075","volume":"6","author":"N Smorgick","year":"2014","unstructured":"Smorgick N, Maymon R. Assessment of adnexal masses using ultrasound: a practical review. Int J Womens Health, 2014,6:857\u2013863","journal-title":"Int J Womens Health"},{"issue":"10","key":"2163_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"I Jacobs","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 1990,97(10):922\u2013929","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"2163_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","volume":"127","author":"MA Karlsen","year":"2012","unstructured":"Karlsen MA, Sandhu N, Hogdall C, et al. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2012,127(2):379\u2013383","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2163_CR14","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2010.03.043","volume":"203","author":"RG Moore","year":"2010","unstructured":"Moore RG, Jabre-Raughley M, Brown AK, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol, 2010,203(3):228.e1\u20136","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2163_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3802\/jgo.2015.26.1.46","volume":"26","author":"S Wilailak","year":"2015","unstructured":"Wilailak S, Chan KK, Chen CA, et al. Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings. J Gynecol Oncol, 2015,26(1):46\u201353","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"2163_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ygyno.2016.03.019","volume":"141","author":"M Yanaranop","year":"2016","unstructured":"Yanaranop M, Tiyayon J, Siricharoenthai S, et al. Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass. Gynecol Oncol, 2016,141(3):479\u2013484","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2163_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","volume":"26","author":"J Prat","year":"2015","unstructured":"Prat J. FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol, 2015,26(2):87\u201389","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"2163_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J, 2005,47(4):458\u2013472","journal-title":"Biom J"},{"key":"2163_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13048-015-0201-z","volume":"8","author":"Y Tian","year":"2015","unstructured":"Tian Y, Wang C, Cheng L, et al. Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women. J Ovarian Res, 2015,8:72","journal-title":"J Ovarian Res"},{"issue":"52","key":"2163_CR20","doi-asserted-by":"publisher","first-page":"e2402","DOI":"10.1097\/MD.0000000000002402","volume":"94","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wang C, Cheng L, et al. Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer. Medicine (Baltimore), 2015,94(52):e2402","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2163_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","volume":"32","author":"R Molina","year":"2011","unstructured":"Molina R, Escudero JM, Auge JM, et al. HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumour Biol, 2011,32(6):1087\u20131095","journal-title":"Tumour Biol"},{"issue":"5","key":"2163_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1158\/1055-9965.EPI-08-1034","volume":"18","author":"CA Shah","year":"2009","unstructured":"Shah CA, Lowe KA, Paley P, et al. Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. Cancer Epidemiol Biomarkers Prev, 2009,18(5):1365\u20131372","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2163_CR23","doi-asserted-by":"publisher","first-page":"c6839","DOI":"10.1136\/bmj.c6839","volume":"341","author":"D Timmerman","year":"2010","unstructured":"Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ, 2010,341:c6839","journal-title":"BMJ"},{"issue":"1","key":"2163_CR24","first-page":"70","volume":"78","author":"AM Sassone","year":"1991","unstructured":"Sassone AM, Timor-Tritsch IE, Artner A, et al. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol, 1991,78(1):70\u201376","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2163_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","volume":"48","author":"T Van Gorp","year":"2012","unstructured":"Van Gorp T, Veldman J, Van Calster B, et al. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses. Eur J Cancer, 2012,48(11):1649\u20131656","journal-title":"Eur J Cancer"},{"issue":"3","key":"2163_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2014.01.005","volume":"132","author":"A Stiekema","year":"2014","unstructured":"Stiekema A, Lok CA, Kenter GG, et al. A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer. Gynecol Oncol, 2014,132(3):573\u2013577","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2163_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00404-013-2901-1","volume":"288","author":"R Moszynski","year":"2013","unstructured":"Moszynski R, Szubert S, Szpurek D, et al. Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors. Arch Gynecol Obstet, 2013,288(6):1377\u20131383","journal-title":"Arch Gynecol Obstet"},{"issue":"1\u20132","key":"2163_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clinbiochem.2015.07.029","volume":"49","author":"Y Xu","year":"2016","unstructured":"Xu Y, Zhong R, He J, et al. Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China. Clin Biochem, 2016,49(1\u20132):32\u201340","journal-title":"Clin Biochem"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-020-2163-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:54:53Z","timestamp":1615596893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-020-2163-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s11596-020-2163-7","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}